Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Sara Pellegrino – Senior Vice President, Investor Relations and Corporate Communications Fred Vogt – Interim President and Chief Executive Officer Igor Bilinsky – Chief Operating Officer Jim Ziegler – Executive Vice President-Commercial Friedrich Finckenstein – Chief Medical Officer Jean-Marc Bellemin – Chief Financial Officer Raj Puri – Executive Vice President, Regulatory Strategy an ...